NIVOLUMAB
Approved small_molecule active
Quick answer
NIVOLUMAB for Melanoma, Renal cell carcinoma is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Melanoma, Renal cell carcinoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active